Bruce Mackle | Investor Relations, LifeSci Advisors |
Dr. Steve Fruchtman | President & Chief Executive Officer |
Dr. Mark Gelder | Chief Medical Officer |
Mark Guerin | Chief Operating Officer & Chief Financial Officer |
Charles Zhu | Guggenheim Securities |
Ahu Demir | Ladenburg Thalmann |
Robert LeBoyer | Noble Capital |
Ladies and gentlemen, thank you for standing by. Welcome to the Onconova Therapeutics Third Quarter 2022 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode.
Following management's prepared remarks, we will hold a question-and-answer session. [Operator Instructions] As a reminder, this call is being recorded today, November 14, 2022.